Multiple malignancies amongst cancer survivors in the Netherlands since 1989 - implications for surveillance
Year: 2012
Type: dissertation
Abstract: Early detection of cancer as well as advances in therapy and supportive care have resulted a \nprolonged survival period of time after cancer. In the Netherlands the 5-year relative survival \nfor all types of cancers combined increased from 47% in 1989-1993 to 59% in 2004-2008. \nOnce patients have survived long enough (i.e. 10 years) since diagnosis of their cancer, their \nlife expectancy usually becomes almost the same as people without a cancer (conditional \n5-year relative survival>95%). A Netherlands Cancer scenario Report expected the prevalence \nof second cancer patients to increase from 14,000 in 1985 to 24,000 (excl. skin cancer) \nin 2000 when assuming an average increase of duration of survival by 1% per annum. The \nSignallling report in 2004 from the Dutch Cancer Society estimated the prevalence of multiple \nmalignancies (MMs) to reach around 100,000 cases in 2015 in the Netherlands due to a \ntwofold number of cancer survivors since 2005. Since a second cancer diagnosis may impair \nsurvival and is likely to affect quality of life amongst cancer survivors we should be interested \nin prevention and early detection and its undoubtedly more complex treatment. \nMMs are defined as two or more primary cancers occurring in an individual that are \nneither an extension, nor a recurrence, nor a metastasis of the first tumor1.
Author: Lifang Liu
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W10379720